The data management approach of the CCNMD is a two tiered plan. Tier one, involves the implementation and maintenance of a data warehouse system that has recently been developed within the Department of Psychiatry center-wide. This system provides access to the contributing projects and cores within the CCNMD system integrated data storage and data query capacity through a secure web-based portal. A 3 server computer cluster and a 2 terabyte mass storage system positioned behind the Mount Sinai fire-wall and further protected by 128 bit encryption constitutes the physical structure for data management. All of the data tables generated by the Brian Bank Core and the Clinical Core during the past 22 years have been integrated into this browser based data warehouse which now contains over 3100 variables and more than 2 million data points. These data sets are available for interrogation and mining to all CCNMD participants through a secure intranet. Also included as part of the electronically available data sets are macro and microscopic images of Brain Bank tissues and PDF files of source documents on which the research data are based. Tier two, involves statistical support for all CCNMD projects and cores. All of the CCNMD projects require considerable statistical data analysis, and because of the complexity of some of the hypotheses addressed a high level of statistical analytic sophistication. While all of the CCNMD investigators are well versed in the statistical approaches that are applicable to their specific hypotheses and projects, this core will provide them with statistical expertise for not only state-of-the-art analysis of their specific data sets, but also for the integration of each projects data with the data derived from the other projects. The integration of cross-project data for statistical analysis will not only be aided by the data management system described, but also by the fact that statistical testing of hypotheses has been an integral part of the development of the aims and hypotheses of each CCNMD project form the time of their inception.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH066392-08
Application #
8080388
Study Section
Special Emphasis Panel (ZMH1)
Project Start
2010-06-01
Project End
2012-05-31
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
8
Fiscal Year
2010
Total Cost
$209,386
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Mitchell, A C; Javidfar, B; Pothula, V et al. (2018) MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice. Mol Psychiatry 23:123-132
Bryois, Julien; Garrett, Melanie E; Song, Lingyun et al. (2018) Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia. Nat Commun 9:3121
Fazio, Leonardo; Pergola, Giulio; Papalino, Marco et al. (2018) Transcriptomic context of DRD1 is associated with prefrontal activity and behavior during working memory. Proc Natl Acad Sci U S A 115:5582-5587
Gusev, Alexander; Mancuso, Nicholas; Won, Hyejung et al. (2018) Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet 50:538-548
Mitelman, Serge A; Bralet, Marie-Cecile; Mehmet Haznedar, M et al. (2018) Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia. Brain Imaging Behav 12:532-546
Gandal, Michael J; Zhang, Pan; Hadjimichael, Evi et al. (2018) Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science 362:
Girdhar, Kiran; Hoffman, Gabriel E; Jiang, Yan et al. (2018) Cell-specific histone modification maps in the human frontal lobe link schizophrenia risk to the neuronal epigenome. Nat Neurosci 21:1126-1136
Hauberg, Mads E; Fullard, John F; Zhu, Lingxue et al. (2018) Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls. Mol Psychiatry :
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302
Curtis, David (2018) Polygenic risk score for schizophrenia is not strongly associated with the expression of specific genes or gene sets. Psychiatr Genet 28:59-65

Showing the most recent 10 out of 153 publications